Short answer · Medically reviewed summary · Last updated: 2026-04-07
IgA nephropathy is generally considered a complex, multifactorial condition rather than a simple hereditary disorder, meaning it results from a combination of genetic susceptibility and environmental triggers. While there is a clear familial clustering observed in some cases, it does not follow a straightforward Mendelian inheritance pattern like autosomal dominant or recessive traits, and most cases occur sporadically. Is IgA nephropathy a strictly hereditary condition? In clinical genetics, we distinguish between "hereditary" (caused by a single gene mutation passed down through families) and "multifactorial" (caused by a combination of multiple genes and environmental factors).
IgA nephropathy is generally considered a complex, multifactorial condition rather than a simple hereditary disorder, meaning it results from a combination of genetic susceptibility and environmental triggers. While there is a clear familial clustering observed in some cases, it does not follow a straightforward Mendelian inheritance pattern like autosomal dominant or recessive traits, and most cases occur sporadically.
In clinical genetics, we distinguish between "hereditary" (caused by a single gene mutation passed down through families) and "multifactorial" (caused by a combination of multiple genes and environmental factors). IgA nephropathy is considered multifactorial. While researchers have identified several susceptibility loci—specifically regions on chromosomes 6 and 22—that may increase the risk of developing IgA nephropathy, these genetic variants do not guarantee the disease will manifest. Most individuals with these genetic markers never develop the condition, suggesting that external factors, such as mucosal infections or gut microbiome composition, play a critical role in triggering the disease process.
Because IgA nephropathy is not a single-gene disorder, we cannot assign a specific percentage risk (such as 25% or 50%) to the children of an affected parent. However, clinical data indicates that first-degree relatives of patients with IgA nephropathy have a higher risk of developing the condition compared to the general population. This "familial aggregation" is often cited in literature, but it is rare to see the disease manifest in every generation. It is important to note that de novo (spontaneous) mutations are not the primary mechanism behind IgA nephropathy; rather, it is the inheritance of a complex "polygenic risk score" that contributes to susceptibility.
Currently, there is no standardized clinical genetic test used to diagnose IgA nephropathy. Diagnosis is primarily confirmed through a kidney biopsy, which reveals the characteristic deposition of IgA-containing immune complexes in the glomerular mesangium. Genetic testing for IgA nephropathy remains largely confined to research settings to better understand the underlying pathophysiology. Because the genetic basis is so complex and involves many genes of small effect, genetic counseling for families is usually focused on:
For families within the IgA nephropathy community, understanding that this is not a traditional "inherited" disease can reduce the burden of guilt often felt by parents. The 347 members of the IgA nephropathy community on DiseaseMaps.org frequently discuss the value of early monitoring. If you have a strong family history, the most effective "genetic" management strategy is proactive clinical monitoring. Regular blood pressure checks and urinalysis can detect early signs of renal involvement, allowing for earlier intervention and better long-term outcomes.
Medical Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.